(ATT) Attendo (publ) - Ratings and Ratios

Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0007666110

ATT: Nursing Homes, Home Care, Respite Care, Specialized Care, Housing Services

Attendo AB (publ) is a leading provider of health and care services across Scandinavia and Finland, specializing in comprehensive care solutions for diverse patient groups. The company operates nursing homes tailored for individuals with dementia or physical care needs, offering 24/7 monitoring and specialized facilities. Its home care services include personalized assistance with daily tasks such as meals, cleaning, and laundry, as well as evening and night care. Additionally, Attendo provides tailored living arrangements for individuals with disabilities, ensuring customized support programs and community integration. The company also offers respite care, short-term accommodation, and companion services, catering to a wide range of care requirements.

Attendos service portfolio extends to specialized care for individuals with neuropsychiatric and psychosocial impairments, providing personalized treatment plans. It operates social-worker supported foster care, crisis and emergency accommodation, HVB-homes, addiction care, and various forms of supportive housing services. The company also delivers rehabilitation care services, focusing on recovery and reintegration into daily life. Founded in 1985, Attendo is headquartered in Danderyd, Sweden, and has established itself as a key player in the Nordic healthcare sector. Web URL: https://www.attendo.com

Ticker Symbol: ATT Exchange: ST Type: common stock Country Origin: Sweden GICS Sub Industry: Health Care Facilities

3-Month Forecast: - Technical Outlook: The stock is expected to maintain its upward momentum, supported by the rising SMA 20 and SMA 50, which are both above the SMA 200. The low ATR of 2.02 indicates reduced volatility, suggesting a stable price movement. - Fundamental Outlook: With a P/B ratio of 1.71 and a P/S ratio of 0.48, the company is undervalued relative to its peers. The RoE of 8.44% reflects stable profitability. The high P/E of 21.37 indicates market confidence in future growth, driven by expanding service offerings and strong cash flow from operations.

Additional Sources for ATT Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

ATT Stock Overview

Market Cap in USD 974m
Sector Healthcare
Industry Medical Care Facilities
GiC Sub-Industry Health Care Facilities
IPO / Inception

ATT Stock Ratings

Growth Rating 46.3
Fundamental 70.6
Dividend Rating 1.0
Rel. Strength 54.3
Analysts -
Fair Price Momentum 65.11 SEK
Fair Price DCF 331.96 SEK

ATT Dividends

Dividend Yield 12m 0.00%
Yield on Cost 5y %
Annual Growth 5y -100.00%
Payout Consistency 45.0%

ATT Growth Ratios

Growth Correlation 3m 1.2%
Growth Correlation 12m 95.9%
Growth Correlation 5y 14.8%
CAGR 5y 14.07%
CAGR/Max DD 5y 0.22
Sharpe Ratio 12m 0.89
Alpha 49.13
Beta 0.349
Volatility 33.87%
Current Volume 177k
Average Volume 20d 204.9k
What is the price of ATT stocks?
As of May 01, 2025, the stock is trading at SEK 65.60 with a total of 177,001 shares traded.
Over the past week, the price has changed by +5.81%, over one month by +9.15%, over three months by +27.88% and over the past year by +56.94%.
Is Attendo (publ) a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Attendo (publ) (ST:ATT) is currently (May 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 70.61 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ATT as of May 2025 is 65.11. This means that ATT is currently overvalued and has a potential downside of -0.75%.
Is ATT a buy, sell or hold?
Attendo (publ) has no consensus analysts rating.
What are the forecast for ATT stock price target?
According to ValueRays Forecast Model, ATT Attendo (publ) will be worth about 70.6 in May 2026. The stock is currently trading at 65.60. This means that the stock has a potential upside of +7.56%.
Issuer Forecast Upside
Wallstreet Target Price 68 3.7%
Analysts Target Price - -
ValueRay Target Price 70.6 7.6%